Intellect Neurosciences has won a notice of allowance (NOA) from the European Patent Office for its OX1, which has been licensed to ViroPharma for Friedrich's Ataxia and other neurodegenerative diseases. The OX1 patent relates to a new ...
Tags: neurodegenerative disease, patent, notice of allowance